Clinical trial
Survey on Drug Use of Micamlo Combination Tablets AP in Patients With Hypertension
NCT01353274 is registered in ClinicalTrials.gov with Boehringer Ingelheim as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Survey on Drug Use of Micamlo Combination Tablets AP in Patients With Hypertension
- Lead sponsor
- Boehringer Ingelheim
- Phase
- Observational
- Overall status
- Completed
- Start date
- May 31, 2011
- Completion date
- August 31, 2013
- Enrollment
- 1,157 (actual)
- Sites
- 254
Conditions
As the registry lists them; a condition with its own page is linked.